• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1120300-12
Device Problems Material Separation (1562); Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Patient Problems Foreign Body In Patient (2687); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/05/2021
Event Type  malfunction  
Manufacturer Narrative
The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a heavily calcified and heavily tortuous vessel in an unspecified artery.The 3.0x12mm xience alpine stent delivery system (sds) stent dislocated from the balloon due to the tortuosity of the vessel.Another xience stent was used to complete the procedure.There was no reported adverse patient effect and there was no clinically significant delay in the procedure.No additional information was provided.
 
Event Description
It was reported that the procedure was to treat a heavily calcified and heavily tortuous vessel in an unspecified artery.The 3.0x12mm xience alpine stent dislocated from the balloon due to the tortuosity of the vessel.Another xience stent was used to complete the procedure.There was no reported adverse patient effect and there was no clinically significant delay in the procedure.Returned analysis identified the inner and outer member (entire distal shaft) were separated 2.5mm distal to the guide wire exit notch and were not returned.It was confirmed that the account was aware of the separation.There is the possibility that the separated portion remains in the patient anatomy.No additional information was provided.
 
Manufacturer Narrative
The device was received.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.H1 - type of reportable event updated from "malfunction" to "serious injury".H6 - health effect - clinical code 4582 was removed and code 2687 was added.H6 - health effect - impact code 2199 removed.
 
Manufacturer Narrative
A visual inspection was performed on the returned device.The reported device dislodged or dislocated and failure to advance were not tested due to the component not being returned.The reported material separation was confirmed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot did not indicate a lot specific quality issue.The investigation determined the reported failure to advance and device dislodged or dislocated are related to the operational context of the procedure.Additionally, the investigation was unable to determine a conclusive cause for the reported material separation.In this case, it is likely that the sds interacted with the heavily tortuous and heavily calcified anatomy, contributing to the noted twisted skive/wire/bayonet and ultimately resulting in the reported failure to advance and subsequent device dislodged or dislocated.Factors that could contribute to material separation include, but not limited to, patient disease state, anatomical morphology, user technique, and interaction with accessory devices.In this case, it is possible that the sds interacted with the challenging anatomy during retraction, contributing to the reported material separation; however, this cannot be confirmed.There is no indication of a product quality issue with respect to manufacture, design, or labeling.B1 - adverse event/product problem "adverse event" was removed.B2 - outcomes attributed to ae "other serious" was removed and replaced with "na".H1 - type of reportable event updated from "serious injury" to "malfunction".H6 - health effect - clinical code 2687 was removed and 4582 added.H6 - health effect - impact code 2199 added.
 
Event Description
It was reported that the procedure was to treat a heavily calcified and heavily tortuous vessel in an unspecified artery.The 3.0x12mm xience alpine stent dislocated from the balloon due to the tortuosity of the vessel.Another xience stent was used to complete the procedure.There was no reported adverse patient effect and there was no clinically significant delay in the procedure.Returned analysis identified the inner and outer member (entire distal shaft) were separated 2.5mm distal to the guide wire exit notch and were not returned.Subsequent to filing the prior reports the following information was received: it was confirmed that the account was aware of the distal shaft separation and confirmed that no part of the device remains in the patient's anatomy.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13043846
MDR Text Key285634725
Report Number2024168-2021-11873
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeBR
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/20/2022
Device Catalogue Number1120300-12
Device Lot Number9081441
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/10/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/16/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/21/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-